VENN STRATEGIES, LLC

Lobbying for TRINETX · Combines access to longitudinal clinical data with analytics to answer research questions.

Filing 4th Quarter - Amendment

4th Quarter (Oct 1 - Dec 31) 2019 · Massachusetts · House · Senate · $30,000.00 income · posted Jul 2, 2026

Lobbying activity 1

Health Issues

Policy issues impacting the use of real-world data in clinical trials.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.